Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$155.97 - $200.09 $332,372 - $426,391
2,131 Added 103.45%
4,191 $723,000
Q1 2022

May 10, 2022

SELL
$181.39 - $234.03 $47,342 - $61,081
-261 Reduced 11.25%
2,060 $388,000
Q4 2021

Feb 15, 2022

BUY
$193.69 - $247.03 $27,697 - $35,325
143 Added 6.57%
2,321 $566,000
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $11,168 - $12,371
-59 Reduced 2.64%
2,178 $423,000
Q2 2021

Aug 13, 2021

SELL
$155.9 - $187.99 $19,331 - $23,310
-124 Reduced 5.25%
2,237 $417,000
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $121,968 - $143,473
847 Added 55.94%
2,361 $371,000
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $628 - $697
4 Added 0.26%
1,514 $250,000
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $192,899 - $232,675
-1,407 Reduced 48.23%
1,510 $250,000
Q2 2020

Aug 17, 2020

SELL
$111.92 - $142.53 $695,694 - $885,966
-6,216 Reduced 68.06%
2,917 $401,000
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $846,263 - $1.32 Million
9,133 New
9,133 $1.08 Million
Q1 2018

Apr 24, 2018

SELL
$71.51 - $84.69 $258,866 - $306,577
-3,620 Closed
0 $0
Q4 2017

Feb 01, 2018

BUY
$63.24 - $72.8 $228,928 - $263,536
3,620
3,620 $261,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Parametrica Management LTD Portfolio

Follow Parametrica Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.